{# ── Billing problem banner: payment failed (past_due) or retries exhausted (unpaid). Pro access is gated off by is_pro until the card is fixed, so prompt the user to update billing. ── #}

Red Flags Detected

  • Going Concern (new) — Company now discloses substantial doubt about ability to continue operations due to insufficient cash to fund operations through the next 12 months.
  • Delisting (new) — Company received Nasdaq deficiency notice for failing to maintain minimum $1.00 bid price and has until August 17, 2026 to regain compliance or face delisting.
  • Securities Litigation (worsened) — Partial dismissal with prejudice indicates some claims survived and litigation continues with a third amended complaint.
NASDAQ: OTLK Outlook Therapeutics, Inc. 10-Q

Outlook Therapeutics flags going concern, misses debt payment, faces Nasdaq delisting

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade OTLK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 27, 2026 5:05 PM